Recurrent or chemoresistant B-cell, CD20-positive low-grade non-Hodgkin’s lymphoma or follicular;
Stage III-IV follicular lymphoma in combination with CVP chemotherapy in previously untreated patients;
Follicular lymphoma (as maintenance therapy after response to induction therapy);
CD20-positive diffuse large B-cell non-Hodgkin’s lymphoma, in combination with CHOP chemotherapy.
Active ingredient: rituximab
Store at a temperature of 4-8 degrees.
100MG/10ML, 500MG/50ML, 1400 MG